CDK9-IN-27 (Compound 6a), a CDK9 inhibitor with an IC50 of 0.424 µM, induces apoptosis and S-phase cell cycle arrest. It exhibits cytotoxicity against HepG2, HCT-116, and MCF-7 cell lines, with IC50 values ranging from 10.31 to 40.34 µM, rendering it applicable in cancer research.
Molekulargewicht:
447.87
Formel:
C23H18ClN5O3
Target-Kategorie:
CDK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
